DOTA-Octreotide
DOTA-Octreotide is composed of chelator DOTA and Octreotide (HY-P0036). DOTA-Octreotide is used for research of cancer, through combination with radioactive elements. DOTA-Octreotide can be used for the synthesis/research of Radionuclide-Drug Conjugates (RDCs).
For research use only. We do not sell to patients.
- CAS No.: 209277-09-8
- Formula: C65H92N14O17S2
- Molecular Weight:1405.64
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All Radionuclide-Drug Conjugates (RDCs) Isoforms
More
Biological Activity
|
RDC Peptide |
Chemical Information
-
CAS No. 209277-09-8
-
Molecular Weight 1405.64
-
Formula C65H92N14O17S2
-
Sequence
DOTA-{d-Phe}-Cys-Phe-{d-Trp}-Lys-Thr-Cys-{Threoninol} (Disulfide bridge: Cys2-Cys7)
-
Sequence Shortening
DOTA-{d-Phe}-CF-{d-Trp}-KTC-{Threoninol} (Disulfide bridge: Cys2-Cys7)
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)